vs
PUMA BIOTECHNOLOGY, INC.(PBYI)与Xperi Inc.(XPER)财务数据对比。点击上方公司名可切换其他公司
Xperi Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍($116.5M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs -4.8%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $1.2M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs -1.0%)
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
Xperi是一家美国跨国科技企业,总部位于加利福尼亚州圣何塞,专注研发消费电子与联网车载软件,以及宽带视频服务媒体平台,业务分为付费电视、消费电子、联网汽车与媒体平台四大板块,旗下拥有DTS、HD Radio、TiVo等知名品牌。
PBYI vs XPER — 直观对比
营收规模更大
XPER
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出32.5%
-4.8%
自由现金流更多
PBYI
多$13.2M
$1.2M
两年增速更快
PBYI
近两年复合增速
-1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $75.5M | $116.5M |
| 净利润 | — | $-17.1M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | -12.7% |
| 净利率 | — | -14.7% |
| 营收同比 | 27.7% | -4.8% |
| 净利润同比 | — | -137.0% |
| 每股收益(稀释后) | $0.26 | $-0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PBYI
XPER
| Q4 25 | $75.5M | $116.5M | ||
| Q3 25 | $54.5M | $111.6M | ||
| Q2 25 | $52.4M | $105.9M | ||
| Q1 25 | $46.0M | $114.0M | ||
| Q4 24 | $59.1M | $122.4M | ||
| Q3 24 | $80.5M | $132.9M | ||
| Q2 24 | $47.1M | $119.6M | ||
| Q1 24 | $43.8M | $118.8M |
净利润
PBYI
XPER
| Q4 25 | — | $-17.1M | ||
| Q3 25 | $8.8M | $-6.1M | ||
| Q2 25 | $5.9M | $-14.8M | ||
| Q1 25 | $3.0M | $-18.4M | ||
| Q4 24 | — | $46.2M | ||
| Q3 24 | $20.3M | $-16.8M | ||
| Q2 24 | $-4.5M | $-30.3M | ||
| Q1 24 | $-4.8M | $-13.1M |
毛利率
PBYI
XPER
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率
PBYI
XPER
| Q4 25 | 22.7% | -12.7% | ||
| Q3 25 | 17.6% | -1.2% | ||
| Q2 25 | 12.7% | -10.5% | ||
| Q1 25 | 8.7% | -14.4% | ||
| Q4 24 | 22.6% | -11.7% | ||
| Q3 24 | 27.4% | -14.0% | ||
| Q2 24 | -4.6% | -18.3% | ||
| Q1 24 | -5.3% | -27.2% |
净利率
PBYI
XPER
| Q4 25 | — | -14.7% | ||
| Q3 25 | 16.2% | -5.5% | ||
| Q2 25 | 11.2% | -14.0% | ||
| Q1 25 | 6.5% | -16.1% | ||
| Q4 24 | — | 37.8% | ||
| Q3 24 | 25.2% | -12.6% | ||
| Q2 24 | -9.6% | -25.3% | ||
| Q1 24 | -11.0% | -11.0% |
每股收益(稀释后)
PBYI
XPER
| Q4 25 | $0.26 | $-0.37 | ||
| Q3 25 | $0.17 | $-0.13 | ||
| Q2 25 | $0.12 | $-0.32 | ||
| Q1 25 | $0.06 | $-0.41 | ||
| Q4 24 | $0.40 | $1.02 | ||
| Q3 24 | $0.41 | $-0.37 | ||
| Q2 24 | $-0.09 | $-0.67 | ||
| Q1 24 | $-0.10 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $96.8M |
| 总债务越低越好 | $22.7M | $27.7M |
| 股东权益账面价值 | $130.3M | $414.1M |
| 总资产 | $216.3M | $615.8M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.07× |
8季度趋势,按日历期对齐
现金及短期投资
PBYI
XPER
| Q4 25 | $97.5M | $96.8M | ||
| Q3 25 | $94.4M | $96.8M | ||
| Q2 25 | $96.0M | $95.1M | ||
| Q1 25 | $93.2M | $88.0M | ||
| Q4 24 | $101.0M | $130.6M | ||
| Q3 24 | $96.7M | $72.7M | ||
| Q2 24 | $96.8M | $92.5M | ||
| Q1 24 | $107.2M | $95.2M |
总债务
PBYI
XPER
| Q4 25 | $22.7M | $27.7M | ||
| Q3 25 | $34.0M | $27.7M | ||
| Q2 25 | $45.3M | $27.7M | ||
| Q1 25 | $56.7M | $27.7M | ||
| Q4 24 | $68.0M | $27.7M | ||
| Q3 24 | $79.3M | $27.7M | ||
| Q2 24 | $90.7M | $27.7M | ||
| Q1 24 | $102.0M | $27.7M |
股东权益
PBYI
XPER
| Q4 25 | $130.3M | $414.1M | ||
| Q3 25 | $115.3M | $421.0M | ||
| Q2 25 | $104.7M | $419.8M | ||
| Q1 25 | $97.1M | $418.9M | ||
| Q4 24 | $92.1M | $429.1M | ||
| Q3 24 | $71.1M | $377.4M | ||
| Q2 24 | $48.5M | $388.7M | ||
| Q1 24 | $51.0M | $399.1M |
总资产
PBYI
XPER
| Q4 25 | $216.3M | $615.8M | ||
| Q3 25 | $202.9M | $628.8M | ||
| Q2 25 | $194.9M | $629.2M | ||
| Q1 25 | $196.2M | $633.5M | ||
| Q4 24 | $213.3M | $667.8M | ||
| Q3 24 | $220.7M | $616.2M | ||
| Q2 24 | $205.0M | $619.2M | ||
| Q1 24 | $214.1M | $630.4M |
负债/权益比
PBYI
XPER
| Q4 25 | 0.17× | 0.07× | ||
| Q3 25 | 0.30× | 0.07× | ||
| Q2 25 | 0.43× | 0.07× | ||
| Q1 25 | 0.58× | 0.07× | ||
| Q4 24 | 0.74× | 0.06× | ||
| Q3 24 | 1.12× | 0.07× | ||
| Q2 24 | 1.87× | 0.07× | ||
| Q1 24 | 2.00× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $14.4M | $4.1M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $1.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 1.0% |
| 资本支出强度资本支出/营收 | 0.0% | 2.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $-5.9M |
8季度趋势,按日历期对齐
经营现金流
PBYI
XPER
| Q4 25 | $14.4M | $4.1M | ||
| Q3 25 | $9.7M | $7.5M | ||
| Q2 25 | $14.1M | $10.1M | ||
| Q1 25 | $3.6M | $-22.3M | ||
| Q4 24 | $15.6M | $1.2M | ||
| Q3 24 | $11.0M | $-4.6M | ||
| Q2 24 | $1.0M | $-2.1M | ||
| Q1 24 | $11.2M | $-49.8M |
自由现金流
PBYI
XPER
| Q4 25 | $14.4M | $1.2M | ||
| Q3 25 | $9.7M | $6.7M | ||
| Q2 25 | $14.1M | $9.5M | ||
| Q1 25 | $3.6M | $-23.3M | ||
| Q4 24 | $15.6M | $-510.0K | ||
| Q3 24 | $11.0M | $-5.6M | ||
| Q2 24 | $1.0M | $-2.6M | ||
| Q1 24 | — | $-51.6M |
自由现金流率
PBYI
XPER
| Q4 25 | 19.1% | 1.0% | ||
| Q3 25 | 17.7% | 6.0% | ||
| Q2 25 | 26.8% | 9.0% | ||
| Q1 25 | 7.7% | -20.5% | ||
| Q4 24 | 26.4% | -0.4% | ||
| Q3 24 | 13.7% | -4.2% | ||
| Q2 24 | 2.1% | -2.2% | ||
| Q1 24 | — | -43.4% |
资本支出强度
PBYI
XPER
| Q4 25 | 0.0% | 2.5% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.0% | 1.6% |
现金转化率
PBYI
XPER
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
XPER
| Pay TV | $56.2M | 48% |
| Connected Car | $31.3M | 27% |
| Consumer Electronics | $17.2M | 15% |
| Media Platform | $11.8M | 10% |